JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, N.
Right arrow Articles by Justice, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, N.
Right arrow Articles by Justice, J. B., Jr.

Vol. 290, Issue 3, 940-949, September 1999

Cationic Modulation of Human Dopamine Transporter: Dopamine Uptake and Inhibition of Uptake1

Nianhang Chen , Clarence G. Trowbridge and Joseph B. Justice, Jr.

Department of Pharmacology, Nanjing Medical University, Nanjing, Peoples Republic of China (N.C.); and Department of Chemistry, Emory University, Atlanta, Georgia (N.C., C.G.T., J.B.J.)

Effects of cations on dopamine (DA) uptake into cells expressing the human dopamine transporter and on inhibition of DA uptake by various substrates and inhibitors were investigated by using rotating disk electrode voltammetry. The Na+ dependence of DA uptake varied with Na+ substitutes, hyperbolic with Li+, almost linear at 1 µM DA but hyperbolic at 8 µM DA with choline, and sigmoidal with K+. With Na+ substituted by Li+, K[DA] decreased and Vapp remained constant with increasing [Na+], whereas K[Na+] decreased and Vapp increased with increasing [DA], suggesting an ordered sequence with Na+ binding before DA. Similar trends for the Na+-DA interactions were observed in the presence of cocaine. Cocaine inhibited DA uptake solely by increasing K[DA], with its Ki not significantly different at 55 and 155 mM [Na+], whereas it inhibited Na+ stimulation by reducing Vapp more than K[Na+] at 1 µM DA, and Vapp only and less potently at 8 µM DA. Thus, cocaine may compete with DA, not with Na+, for the transporter, and might not follow a strictly ordered reaction with Na+. With Na+ substituted by K+, K[DA] or K[Na+] became insensitive to Na+ or DA. K+ impaired the DA uptake mainly by reducing Vapp, but affected cocaine inhibition by elevating Ki. Despite their different patterns for inhibiting DA uptake, nontransportable inhibitors cocaine, methylphenidate, mazindol, and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenyl-2-propyl)piperazine (GBR12909) showed similarly modest Na+ dependence in their Ki values. In contrast, substrates DA, m-tyramine, and amphetamine displayed a similarly stronger Na+ requirement for their apparent affinities.


0022-3565/99/2903-0940$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H. H. Sitte, B. Hiptmair, J. Zwach, C. Pifl, E. A. Singer, and P. Scholze
Quantitative Analysis of Inward and Outward Transport Rates in Cells Stably Expressing the Cloned Human Serotonin Transporter: Inconsistencies with the Hypothesis of Facilitated Exchange Diffusion
Mol. Pharmacol., April 16, 2001; 59(5): 1129 - 1137.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Chen, J. V. Ferrer, J. A. Javitch, and J. B. Justice Jr.
Transport-dependent Accessibility of a Cytoplasmic Loop Cysteine in the Human Dopamine Transporter
J. Biol. Chem., January 21, 2000; 275(3): 1608 - 1614.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.